Every year, hundreds of thousands of patients worldwide undergo radiotherapy for primary brain tumours and for brain metastases originating from extracranial tumours [1] [2] [3] [4] [5] . Radiation is an indispensable mainstay treatment for the majority of these brain tumours [6] [7] [8] [9] . Brain radiotherapy is subdivided into whole-brain radiotherapy (WBRT) and partial-brain radiotherapy (PBRT) 4, 10, 11 . Stereotactic radiosurgery (SRS) relies on precise 3D imaging and localization to deliver ablative doses of radiation to the tumour, and can substantially reduce exposure of healthy brain tissue 12 . These modes of brain radiotherapy can be used for the following clinical objectives: long-term tumour control or cure as mono therapy or combined therapy, salvage treatment for slowing tumour growth or palliation, and prophylaxis to kill metastatic cells that would otherwise become established in the brain 6, [13] [14] [15] . Each year in the USA, ~100,000 patients with a brain tumour who receive brain radiation survive >6 months, and 50-90% of these individuals exhibit cognitive dysfunction that is often progressive and disabling 3, [16] [17] [18] . Affected cognitive domains include learning, memory, processing speed, attention, and executive function 8, 19 . Patient quality of life (QoL) is now accorded great importance in clinical oncology, and radiotherapyinduced cognitive decline erodes patients' perception of QoL, as revealed by a questionnaire from the cognitive section of the European Organization for Research and Treatment of Cancer (EORTC) 18, [20] [21] [22] . The WHO describes health as a "state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity" (see WHO description of health). In keeping with this perspective, the Response Assessment in Neuro-Oncology (RANO) working group recommended that neurocognitive outcome be considered as one of the primary endpoints in brain tumour clini cal trials 23 . Despite the rapidly expanding concern about radiation-induced cognitive disability, the pathophysiology driving the progression of this syndrome remains poorly understood, and there are no effective preventive measures or long-term treatments 24 . The pathophysiological basis of radiation-induced cognitive decline is complex and involves several interacting and synergistic mechanisms [25] [26] [27] . Historically, the primary focus has been on markers of damage and cognitive Abstract | Standard treatment of primary and metastatic brain tumours includes high-dose megavoltage-range radiation to the cranial vault. About half of patients survive >6 months, and many attain long-term control or cure. However, 50-90% of survivors exhibit disabling cognitive dysfunction. The radiation-associated cognitive syndrome is poorly understood and has no effective prevention or long-term treatment. Attention has primarily focused on mechanisms of disability that appear at 6 months to 1 year after radiotherapy. However, recent studies show that CNS alterations and dysfunction develop much earlier following radiation exposure. This finding has prompted the hypothesis that subtle early forms of radiation-induced CNS damage could drive chronic pathophysiological processes that lead to permanent cognitive decline. This Review presents evidence of acute radiation-triggered CNS inflammation, injury to neuronal lineages, accessory cells and their progenitors, and loss of supporting structure integrity. Moreover, injury-related processes initiated soon after irradiation could synergistically alter the signalling microenvironment in progenitor cell niches in the brain and the hippocampus, which is a structure critical to memory and cognition. Progenitor cell niche degradation could cause progressive neuronal loss and cognitive disability. The concluding discussion addresses future directions and potential early treatments that might reverse degenerative processes before they can cause permanent cognitive disability.
. Stereotactic radiosurgery (SRS) relies on precise 3D imaging and localization to deliver ablative doses of radiation to the tumour, and can substantially reduce exposure of healthy brain tissue 12 . These modes of brain radiotherapy can be used for the following clinical objectives: long-term tumour control or cure as mono therapy or combined therapy, salvage treatment for slowing tumour growth or palliation, and prophylaxis to kill metastatic cells that would otherwise become established in the brain 6, [13] [14] [15] . Each year in the USA, ~100,000 patients with a brain tumour who receive brain radiation survive >6 months, and 50-90% of these individuals exhibit cognitive dysfunction that is often progressive and disabling 3, [16] [17] [18] . Affected cognitive domains include learning, memory, processing speed, attention, and executive function 8, 19 .
Patient quality of life (QoL) is now accorded great importance in clinical oncology, and radiotherapyinduced cognitive decline erodes patients' perception of QoL, as revealed by a questionnaire from the cognitive section of the European Organization for Research and Treatment of Cancer (EORTC) 18, [20] [21] [22] . The WHO describes health as a "state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity" (see WHO description of health). In keeping with this perspective, the Response Assessment in Neuro-Oncology (RANO) working group recommended that neurocognitive outcome be considered as one of the primary endpoints in brain tumour clini cal trials 23 . Despite the rapidly expanding concern about radiation-induced cognitive disability, the pathophysiology driving the progression of this syndrome remains poorly understood, and there are no effective preventive measures or long-term treatments 24 .
The pathophysiological basis of radiation-induced cognitive decline is complex and involves several interacting and synergistic mechanisms [25] [26] [27] decline appearing over 6 months to 1 year or later after irradiation 5 . For example, white matter deterioration has been presumed to be a major factor that underlies progressive cognitive decline which is generally apparent ~1 year after brain irradiation 18 . However, reports describing the absence of demonstrable white matter changes despite the presence of cognitive impairment inevitably led to questions over this presumption 18, 28, 29 . More-sensitive imaging modalities, such as diffusion tensor imaging (DTI), along with new lines of inquiry and enhanced experimental techniques in animal and cell-based models of radiation-induced CNS injury have revealed subtle evidence of damage to white matter, the cortex, and a range of neuroanatomical domains much sooner than 6 months 5, 18 . In many such studies, CNS changes were observed within hours, days, or weeks of irradiation. For the present Review, the term 'early' refers to acute events developing at ≤4 weeks (1 month) after radiation exposure 27, 30, 31 . We, and others, postulate that previously undetected and comparatively subtle early manifestations of irradiation damage to the CNS can synergize over time to form long-term macrostructural and microstructural abnormalities, resulting in permanent cognitive disability 5, 18, 25 . Early changes that are not detectable on the gross anatomical level -including a decline in oligodendrocytes, microvascular damage, subtle loss of white matter integrity as seen on DTI, neuroinflammation, and disturbances of neuronal micromorphophysiology -can interact and progressively alter neuronal stem cell niches to impede neuronal function, viability, and progenitor cell differentiation 5, 18, 30 . This process could result in long-term dysfunction and depletion of neurons, and contribute to cognitive decline 4, 5, 32, 33 . This Review begins by delineating the rationale for CNS radiotherapy and identifying the cognitive domains that are most often affected by it. Next, we describe the time course of cognitive deterioration, and the evidence acquired from preclinical models supporting the concept that early radiation-induced subtle changes in the brain are precursors to long-term, permanent CNS dysfunction (FIG. 1) . Evidence gathered via the longitudinal imaging of brain injury in human radiotherapy patients is then addressed in the context of early and long-term CNS deterioration and cognitive disability, and major hypotheses of radiation-induced cognitive decline. The concluding discussion transitions to future directions and to potentially relevant opportunities for early therapeutic interventions, based on early CNS damage that can be exploited to impede progressive cognitive deterioration [3] [4] [5] 18, 30, 33, 34 .
Intracranial radiotherapy and cognition
The initial barrier to success in treating brain tumours is treatment resistance and local treatment failure, evidenced by recurrence and expansion at the initial surgical resection site 35, 36 . Several biological processes contribute to treatment failure in both primary and metastatic brain tumours, but it is generally held that the key obstacle is the inability of drugs to attain effective intratumoural concentrations 36, 37 . By contrast, radiation uniformly penetrates both the brain and tumour parenchyma, overcomes resistant cells, and thus is an essential therapeutic modality 6, 8 . For example, adult patients with nondisseminated medulloblastoma who receive craniospinal radiation and chemotherapy have a 5-year survival of 70% 38 . Radiation necrosis occurs in a minority of patients, and its probability is low at doses below 50 Gy (given in 2 Gy fractions) 6, 39 . However, the incidence increases substantially with escalating radiation dose, fraction size, and the use of chemotherapy 39, 40 . The most common neurotoxic effect of cranial radiation at any patient age is not focal necrosis but diffuse cerebral injury 41 . Importantly, radiation-induced cognitive decline occurs as a result of doses much lower than those that can cause radionecrosis 33, 42 .
Affected brain areas
Despite its undisputed therapeutic importance, radiation often unavoidably damages the brain and affects cognition 27 . The neurocognitive domains thought to be most affected by radiation are verbal and non verbal memory, executive function, sustained attention, and information processing speed 8, 43 . Of the brain structures most commonly affected, the hippo campus is instrumental in learning and memory, whereas the prefrontal cortex (PFC) has a key role in executive functioning 27, [44] [45] [46] . The underlying brain networks involved in sustained attention and processing speed are thought to be more distributed in nature, with most evidence suggesting that they rely on a complex frontal-subcortical network that involves both cortical and white matter structures 47, 48 . Radiation injury can affect some or all of these pathways, is multifactorial and complex, and is characterized by vascular abnormalities, inflammation, gliosis, demyelination, and, with high doses, often white matter necrosis 3, 49 .
Time course of cognitive decline
Wu and colleagues have noted that attention has largely focused on potential mechanisms of cognitive deterioration appearing at 6 months to 1 year following brain irradiation, rather than early abnormalities and how they can evolve over time 5, 50 . The cognitive decline developing
Key points
• Intracranial radiotherapy leads to permanent and substantial cognitive disability in 50-90% of patients • The pathophysiology of radiotherapy-associated cognitive disability remains poorly understood and there are no effective preventive measures or long-term treatments • Historically, most research has addressed markers of damage and the cognitive decline that appears 6 months to 1 year or more after irradiation • More-sensitive imaging techniques have revealed subtle evidence of CNS damage much sooner than 6 months after radiation • These early forms of CNS damage can persist and synergize over time to cause long-term, irreversible deficits in neurons and supporting cell lineages that are vital to cognition • Consideration of early forms of radiation-induced CNS damage could help to identify early treatments that can reverse degenerative processes before they cause permanent disability after 6 months is considered to be progressive and irreversible, and is thus of the greatest concern 6,18,27 (FIG. 2) .
In the adult patient population, which is the focus of this Review, radiation-induced neurocognitive decline follows a biphasic pattern beginning with a transient cognitive decline at approximately 4 months after treatment, followed by an improvement, and then a progressive, irreversible deterioration in cognitive functioning at 12 months or later after irradiation 6 . However, it is important to note that tumour progression during this time period could also adversely affect cognition, thereby confounding neuroimaging and the measurement of radiation-induced cognitive decline in many studies.
The role of radiation dosing regimen
Comparatively recent reports, starting at about 2004, suggest that the brain irradiation dosing scheme has an important influence on specific pathologies in the human and animal brain 9, 28, 51 (TABLE 1) . In rats, a high single intracranial dose (25 Gy) of 250 kV X-rays resulted in an initial early drop in oligodendrocyte numbers, which was followed by a variable pattern of oligodendrocyte markers for several months, and eventually an apparently permanent decline at about 12-15 months after irradiation 52 . Moreover, at 15 months, a diffuse pattern of myelin loss was observed throughout the corpus callosum as well as the fimbriae, the external capsule and the deep white matter 52 . By contrast, fractionated intracranial irradiation delivered to middle-aged (12 months) rats as nine exposures of 5 Gy over 4.5 weeks for a total of 45 Gy -a regimen that closely emulated human radiotherapy treatment schedules -caused no gross changes in white matter morphology and structural integrity 12 months after the treatment regimen finished 29 (TABLE 1) , but the rats showed hippocampal and nonhippocampal dependent cognitive deficits, along with glutamate receptor abnormalities 17 .
Early CNS damage
Perhaps somewhat surprisingly, early functional changes in the CNS after irradiation were already noted in animal models decades ago. In 1960, altered hippocampal firing activity persisting for 7 days was reported in cats after 4 Gy of X-rays 53 . Almost two decades later, in 1978, immediate alterations were described in the firing patterns of rabbit hippocampal neurons after 4 Gy of gamma radiation 54 . In 1993, 5 Gy irradiation was reported to result in decreased synaptic efficacy in guinea pigs soon after irradiation, with apparent recovery by 5 days 55 . These results suggest that the hippo campus expresses radiation-induced damage early, and an important conceptual question that has not been addressed until quite recently is whether such early changes are somehow related to later dysfunction, progressive deterioration, and permanent cognitive deficits.
Vascular damage
Evidence from animal models. Early vascular disruption in preclinical models, such as the rabbit ear, was first reported in the 1950s: in these early studies, oedema developed within hours of a single radiation dose, followed by vascular dysfunction months later 56, 57 . Since then, a considerable body of evidence has accumulated, showing that radiation leads to rapid destabilization of the plasma membrane in various cell types, including the vascular endothelium 3, 58, 59 . In a rat study, cranial irradiation reduced endothelial cell density in the rat brain within 1 day independent of the dose (5 Gy, 25 Gy, 40 Gy or 60 Gy). The loss of endothelial cells persisted for 1 month after exposure and was followed by a slow dose-independent decrease in cell numbers for 6 months; the cell population remained depleted thereafter 31 .
Evidence from human patients. The findings in animal models are in line with reports from human patients, in whom microvascular sequelae of endothelial degeneration can occur months to years after the initial radiation-induced damage, and include telangiectasias, microvascular dilatation, as well as thickening and hyalinization of the vessel wall 60 . Such changes can trigger ischaemic strokes, cerebral microbleeds, and occlusion Nature Reviews | Neurology of small vessels, leading to local necrosis and extravasation with subsequent demyelination 61 . Intracerebral cavernous malformations, which are susceptible to bleeding, have been observed in human patients with a median latency of 3-6 years following CNS irradiation 49, 62 . Even with conformal irradiation techniques, certain brain areas receive moderate to high doses of radiation, with potential to damage the vasculature 63 . Disturbances of cerebral blood flow have been associated with cognitive disability, and the extent of hypoperfusion has correlated with the depth of cognitive deterioration 64, 65 . Vascular damage and associated sequelae leading to poor perfusion of brain tissue can cause secondary local demyelination and focal necrosis, which degrade cognition 39 . Vascular endothelial and glial cell loss has been presumed to cause white matter damage and subsequent cognitive impairment 66 . White matter networks have an essential role in supporting cortical function, and cognitive dysfunction has been linked to damage within these networks 27, 67 (FIGS 3, 4) .
Limitations to therapeutic approaches. The progressive cognitive decline that occurs after WBRT is not necessarily caused by radiation-induced vasculopathy alone. In rats, drugs such as the peroxisome proliferatoractivated receptor-γ (PPAR-γ) agonist pioglitazone and the angiotensin-converting enzyme (ACE) inhibitor ramipril have been reported to prevent radiationinduced cognitive decline, but they do not improve the microvasculature once it has been damaged and depleted after irradiation 18, 68 .
Astrocyte damage
Glial cells comprise a major proportion of the cellular population of the brain, where they control a range of essential functions, and these cells have long been implicated as a causative factor in radiation-induced cognitive decline 69 , 70 . How glial cells are affected by radiation and how they contribute to radiation-induced cognitive decline remains unclear. Astrocytes are glial cells that have a major role in the mature CNS, supporting neurons, maintaining homeostasis, and modulating neuro transmitter dynamics 71 . Following intracranial irradiation, astrocytes proliferate and form scar tissue, a process referred to as reactive gliosis 72 . Characteristic features of reactive gliosis include hypertrophy of astrocytic processes, upregulation of intermediate filaments, and increased expression of glial fibrillary acidic protein (GFAP) 73 , 74 . A single dose of 15 Gy radiation to the rat brain has been reported to increase the levels of inflammatory markers in astrocytes at 30 minutes and GFAP levels at 6 hours, with a further increase at 24 hours, which the authors interpreted as the onset of gliosis 72, 75 . Prostaglandin E 2 (PGE 2 ) released from irradiated microglia seemed to trigger the radiation-induced gliosis 72 . The influence of neuroinflammation on the effects of astrocytic activation and dysfunction on the white matter, and the role of neuroinflammation in cognitive decline in general require further investigation. Irradiation of microglia-astrocyte co-cultures and astrocyte monocultures has been reported to lead to the expression of inflammatory cytokines 75 . Some evidence indicates that treatment of cultured rat astrocytes with the vasodilator peptide Ang 1-7 might prevent radiationinduced mitogen-activated protein (MAP) kinase activation as well as inflammation, which could in theory reduce radiation-induced cognitive impairment 75 .
Oligodendrocyte loss
Oligodendrocytes, which produce and maintain myelin sheaths along axons, are thought to be the most radiationsensitive glial cell type in the CNS. In rodents, the number of oligodendrocytes reduces throughout the brain within a few hours of intracranial irradiation 76, 77 . The majority (>75%) of cells capable of division in the adult brain are oligodendroglial precursors, and loss of these cells is presumed to diminish the replacement of oligodendrocytes 52 . In animal models, cranial irradiation has been linked with white matter injury such as focal demyelination and necrosis 78, 79 . In one rat study, head irradiation (25 Gy of 250 Kv X-rays) reduced the number of oligodendroglial lineage cells, and caused myelin fragmentation, but not vascular damage 52 .
Neurogenesis and cell differentiation
Adult neurogenesis mainly occurs in two brain regions: the subgranular zone (SGZ) in the hippocampal dentate gyrus, and the subventricular zone (SVZ) 80, 81 . Radiation is now known to suppress the proliferation of hippocampal SGZ progenitor cells and their differentiation into neurons [82] [83] [84] [85] . Neurogenesis in the murine hippocampus is reduced after 5 Gy or 10 Gy of intracranial X-rays, which is associated with impaired spatial learning 86, 87 . By contrast, in one study in rat pups, exposure of in vitro subventricular zone progenitor cells to 8 Gy of γ-rays affected neither the percentage of stem cells nor their proliferation, although progression through the cell cycle was markedly delayed, and the proliferation of a glialrestricted precursor was increased 88 . These findings from the hippocampus all align with other studies in preclinical models and with human participants that have uncovered moderate cognitive deficits in the absence of gross structural changes on neuroimaging. Radiation-induced hippocampal impairment is currently thought to derive from damage to differentiated neural cells, altered neurogenesis 89 , and the resulting loss of hippocampal plasticity 82, 83, 90 . In line with this theory, human neural stem cell transplantation has been reported to attenuate radiation-induced cognitive dysfunction in head-irradiated mice 91, 92 . The hippo campus, entorhinal cortex, perirhinal cortex, and parahippocampal cortex are particularly sensitive to vascular injury, and radiation has been hypothesized to cause vascular rarefaction in the hippocampus and cognitive dysfunction that is reversible with hypoxia 65, 93 .
Markers for radiation-induced inflammation.
Astrocytes and microglia respond to brain irradiation by secreting factors that induce widespread neuroinflammation that can alter cell differentiation in the CNS 25, 94 . Proinflammatory cytokines, such as IL-1β, tumour necrosis factor (TNF), IL-6 and IL-18 have been measured in specific regions of the brain following radiation exposure 95 . Inflammatory markers such as GFAP, intercellular adhesion molecule-1 and NF-κB have also been identified in irradiated brain tissue 96 . Cyclooxygenase-2 (COX-2) pathways have been implicated in neuroinflammation following intracranial irradiation, and, as mentioned earlier, the expression of PGE 2 has been suggested as a cause of radiation gliosis 73, 97 . Examination of neuropathological markers of neuro genesis and inflammation in the human hippocampus after intracranial radiation treatment for early myelo genous leukaemia and medulloblastoma showed increased expression consistent with inflammation, with virtually complete inhibition of neurogenesis 98 . Inflammation in the hippocampal microenvironment causes micro vascular damage, which also results in the release of signalling molecules, thereby changing the progenitor cell microenvironment in a way that suppresses differentiation to the neuronal phenoptype 94, [98] [99] [100] [101] . A trophic relationship exists between microvessels and neural progenitors, and the levels of vascular endothelial growth factor (VEGF) in the hippocampus have been shown to affect hippo campal angiogenesis and neurogenesis, and to modulate hippocampal plasticity of mature neurons 102, 103 .
Therapeutic prospects of anti-inflammatory agents:
evidence from animal models. The above findings suggest potential therapeutic strategies such as the use of anti-inflammatory agents and implantation of neural stem cells 94, 98 . Pharmacological suppression of neuroinflammation with MW01-2-151SRM (MW-151), a selective inhibitor of proinflammatory cytokine production, during a 9-month period following a single intra cranial 10 Gy dose of gamma radiation to adult male rats resulted in a higher proportion of hippocampal progenitors adopting a neural instead of a glial fate compared with untreated controls 10 . The authors of the study suggested that this outcome was attributed to an improved neurogenic signalling microenvironment. Importantly, the comparatively long time span of this study points to the possibility that neuroinflammation could be chronic after irradiation, and exert protracted effects on the neuronal population, glial cells, and white matter, thereby driving progressive cognitive deterioration 10, 27 .
Damage to mature neurons
Until the past few years, mature neurons have been regarded as essentially inert to therapeutic levels of radiation 5, 18, 104 . However, some researchers, drawing on both old and new observations, posit that differentiated Note apparent effect of dose rate; according to histology, a low dose rate avoided white matter abnormalities, despite cognitive deficits in this model and with this dosing schedule.
Delayed Match-to-Sample
A test used to assess non-verbal elements of short-term memory in humans and primates: the participant must recall whether a stimulus matches a previously presented 'sample' stimulus.
neurons are radiosensitive, and suggest that it is neuronal dysfunction and not neuronal loss that drives radiation-induced cognitive deterioration 5, 90 . In accordance with this view, young adult male rats show reduced hippocampal neurogenesis after irradiation, despite pharmacological blockade of angiotensin II mediated inflammation, yet, importantly, these animals did not exhibit radiation-induced cognitive impairment 69 . A possible explanation for this observation is that the neuronal precursor population is substantially smaller than the mature neuronal compartment; hence, disruption of neuronal precursor cells could be insufficient to cause identifiable hippocampal cognitive deficits 34 .
Shi and co-workers demonstrated cognitive impairment in rats after fractionated WBRT, yet quantitative analysis of hippocampal neuron number and myelin integrity in the same model indicated neither hippocampal loss of neurons nor changes in myelin integrity 2, 17, 29, 53 . Why the findings of this study differ from other reports is not clear; possibilities include the choice of rodent model and radiation dosing scheme. Another possibility is that microanatomical and functional deficits at the neuronal level occur soon after irradiation, without an immediate loss of neuronal density, apparent white matter damage or detectable loss of grey matter volume.
Early microanatomical abnormalities.
In a 2011 study, healthy adult male rhesus monkeys that received head irradiation (40 Gy in 5 Gy fractions) but no chemotherapy or surgery showed impaired Delayed-Match-to-Sample test performance and reduced prefrontal cortical glucose uptake 105 . The pattern of cognitive decline in the monkeys over the course of 11 months closely mirrored the cognitive course of human patients receiving intracranial radiotherapy 105 . The rhesus monkey model replicates many features of human patients, and these data brings up the clinically important question of whether the cognitive decline observed in rhesus monkeys was preceded by early subtle CNS damage. Possible microanatomical correlates of early radiation-induced neuronal dysfunction include changes in neuronal dendritic spine density and morphology.
Dendritic spines are actin-rich protrusions of neuronal dendrites and are the sites of synaptic contact and excitatory synaptic transmission [106] [107] [108] [109] . Morphophysiology of dendritic spines is thought to provide the basis of Figure 3 | Pathogenesis of radiation-induced long-term cognitive decline. This detailed schematic illustration depicts the major mechanisms proposed to contribute to radiation-induced cognitive decline. PFC, prefrontal cortex.
specific components of cognition, such as neuronal plasticity, including long-term potentiation (LTP) [106] [107] [108] [109] . These highly dynamic structures are populated by N-methyl-d-aspartate (NMDA) type glutamate receptors that are activated by strong synaptic input 109 . Activation of NMDA receptors triggers calcium flux into the dendritic spines and cytoskeletal rearrangement that generates larger spines with stronger synapses. Such changes in synaptic strength are thought to be the primary basis of learning and memory 109 . Links to cognitive decline. Combined histological and behavioural testing data from rats has identified a clear relationship between dendritic spine density in the hippocampus and memory 107 . Early-life stress in humans and animals, as well as mental illness in humans, can cause atrophy of PFC dendrites and spines, which is associated with working memory impairment 110 . Dendritic spines in the pyramidal neurons of the PFC and the hippocampus -brain structures which orchestrate executive function and memory, respectively -change with ageing, and this change correlates with cognitive decline 111 . Such changes have also been reported in the context of brain irradiation. Prenatal irradiation of squirrel monkeys (2 Gy of X-rays) leads to changes in dendritic morphology 112 . In mouse hippocampal slices, doses of 0.1 and 1 Gy of protons or 1 and 10 Gy of X-rays result in early (10 and 30 days post-irradiation) alteration of dendritic morphology and plasticity 30, 34 . At 30 days, notable reductions were observed in the number of dendritic branches, branch points, and dendritic length, indicating diminished dendritic complexity 30, 34 . In aggregate, these results strongly implicate early microstructural damage to neurons as a component of the cognitive decline seen in preclinical models and in humans after cranial irradiation.
Changes in the CNS microenvironment
Neurogenesis, differentiation and maturation. The ability of the hippocampus to subserve cognition and memory depends on neurogenesis and the differentiation of thousands of neurons each day 113 . These neurons are generated from progenitors in the SGZ of the dentate gyrus (DG), which secrete VEGF 114, 115 . Immature neurons are mainly postmitotic and migrate into the DG granule cell layer (GCL) where they differentiate into mature neurons 116 . Mature glutamatergic neurons in the GCL of the DG form spines in the molecular layer of the hippocampus, where they receive input from the entorhinal cortex 116 . Ambient γ-aminobutyric acid (GABA) is instrumental for the proper maturation of hippocampal neurons 117 . The constant flow of neurogenesis and neuronal maturation is supported by an exquisite niche comprised of glial cells, neurons, Wnt-secreting astrocytes, oligo dendrocytes, extracellular matrix and remodeling microvasculature 32, 114, 118 . Damage to any component of this niche can be expected to dysregulate neuro genesis. Implantation of neuronal precursor cells has been found to mitigate radiation-induced cognitive decline, although non-irradiated neural precursor cells did not differentiate into neurons when implanted into the irradiated hippo campus 89, 91, 119 . The failure to differentiate could have resulted from an altered hippocampal microenvironment caused by disruption of micro vascular angiogenesis associated with adult neurogenesis, and a marked increase in the number of activated microglia, triggering inflammation within the neurogenic zone 89, 93 . In a 2013 study, however, a high (8 Gy) single dose of brain irradiation caused progressive depletion of neurogenesis in young male mice over 1 year, without disrupting the neurovascular niche 120 .
Nature Reviews | Neurology In addition, damage to the feeding microvessels not only compromises white matter but also has adverse effects on the perfusion of other key CNS elements, such as astrocytes, which provide metabolic and functional support to neurons.
Homer1a
Homer1a is a protein expressed by neurons that selectively inhibits the binding of family 1 metabotropic glutamate receptor (mGluR) to the synapse.
Signalling dysfunction. Several researchers have speculated that early dysfunction of surviving neuronal cells alters the signalling microenvironment, thus influencing progenitor cell differentiation and cognitive capacity over the long-term 5, 121, 122 . In one study, the ex vivo irradiated rat hippocampal dentate gyrus exhibited early decreases in tyrosine phosphorylation and loss of excitatory NMDA receptors from the cell surface; simultaneously, the surface expression of GABA receptors was increased 5 . Subtle changes have been detected in other potentially clinically relevant signalling molecules in both the hippo campus and cortex. For example, the Homer1a receptor binding protein in young adult male rats was elevated in the hippo campus and decreased in the cortex at 48 h after 40 Gy of fractionated WBRT 4, 123 . At 2 months after irradiation, Homer1a expression was reduced in both the cortex and hippocampus, and these changes correlated with downregulation of hippocampal glutamate receptor 1 and protein kinase C γ , and cortical upregulation of glutamate receptor 1 and protein kinase C γ (REF. 4 ). The clinical relevance of these experimental observations lies in the fact that overexpression of Homer1a in the hippo campus is known to abolish maintenance of synaptic plasticity (CA3-CA1 LTP), and to impair working memory [124] [125] [126] . These functional hippocampal effects are replicated by radiation exposure 50, 127 . Over the long term (months to years), dysregulated signalling can cause hippo campal precursor cells to differentiate into glia rather than neurons, resulting in a loss of neurons and the plasticity required for learning, memory, and other aspects of cognition 102, [128] [129] [130] . Importantly, other radiation-induced effects, such as inflammation, can interact with signalling changes within neurogenic niches to worsen dysregulation of progenitor cells in the hippocampus and elsewhere in the brain. Such effects may have considerable clinical relevance in terms of identifying potential early therapeutic targets.
Neuroimaging of early CNS changes

Gross CNS changes
At present, imaging is the only way to record CNS damage in a patient receiving radiotherapy over time. Both white and grey matter changes, especially in the frontal, temporal and hippocampal areas, have key roles in cognition. Detection and interpretation of white and grey matter damage with standard MRI approaches is challenging. One factor affecting the detectability of white matter damage via imaging is age 18, 79, 105, 113 (FIG . 5; TABLE 1) . A study of patients with glioblastoma found that standard chemoradiation treatment led to progressive volume loss in the non-tumour-bearing brain hemisphere, with DTI changes in the subventricular (progenitor cell) zone 131 . In a 2016 study in patients with high-grade glioma, cortical volumetry with high-resolution MRI revealed dose-dependent cortical atrophy 1 year after PBRT 132 (FIG. 6) ; the dose-dependent cortical atrophy was particularly pronounced in the limbic and temporal lobes. The same researchers went on to study the selective vulnerability of cerebral cortex, showing that regions critical for higher-order cognition (entorhinal cortex and inferior parietal cortex) are the most sensitive to radiation-related atrophy 133 . In another study, the same investigators analysed the probability of cortical atrophy in 15 patients with highgrade glioma at 1-year after radiotherapy, and radiation dose was fitted using logistic mixed effects modelling 134 . Cortical sparing was implemented using two strategies: region-specific sparing using model parameters, and nonspecific sparing of all normal brain tissue, showing that advanced planning techniques can enable sparing of eloquent cortex 134 .
The hippocampus
Neuroimaging evidence for radiation-induced hippocampal changes is conflicting. A study in patients with head or neck cancer who received low-dose incidental radiotherapy to the hippocampus found no volume changes, and the above discussed study in patients with glioblastoma found no hippocampal volume changes 6 months after the beginning of chemoradiation therapy 131, 135 . However, one study from 2016 found progressive hippocampal volume loss after chemo radiation in patients with malignant glioma 136 , and analysis of hippocampal volume changes after PBRT in patients with primary brain tumours revealed substantial radiation Nature Reviews | Neurology .
Diffusion-weighted imaging
Measures and models the diffusion of water at the cellular level.
dose-dependent atrophy, with a 6% volume loss 1 year after irradiation in regions receiving high dose 137 (FIG. 7) . Studies to correlate imaging biomarkers with neurocognitive effects in patients with brain tumours are underway. A pilot functional imaging study using FDG-PET showed that decreases in CNS metabolism after radiotherapy correlated with diminished problem solving skills and cognitive flexibility 63 . None of the neuroimaging studies published to date have reported early cognitive changes; however, it is plausible that changes in neuronal structure and function can occur early along with vascular damage and inflammation, eventually leading to volume changes that are detectable on imaging.
Magnetic resonance spectroscopy
In human patients, changes in chemical constituents of the brain might indicate early neuronal damage after brain irradiation 138 . One such potential marker is N-acetylaspartate (NAA), which is predominantly expressed in neuronal bodies; decreased NAA levels are, therefore, considered to indicate neuronal loss. In one study of patients with brain tumours, a decline in the creatine-NAA ratio was reported for 1 month after WBRT (60 Gy given in fractions of 1.8-2 Gy) 138 . The authors of the study suggested that, given that neuronal disintegration or attendant demyelination (as indicated by increased levels of choline-containing compounds) was not seen, the increased creatine-NAA is more likely to have been the result of neuronal dysfunction, possibly attributable to mitochondrial injury rather than neuronal loss 138 . Moreover, early, persistent NAA decreases have been reported in patients with brain tumours at 3 weeks, 1 month and 6 months after 50.4-59.4 Gy of fractionated PBRT 139 . These patients had low-grade glioma or benign brain tumours, and, importantly, NAA changes developed in brain regions that seemed normal on MRI 139 . In a small study of lung cancer patients receiving either palliative or prophylactic treatment fractionated at comparable doses (30-37.5 Gy WBRT), similar decreases in NAA levels were observed in both prophylactic and palliative groups 140 . The timeframes described by both of these studies align with the timeframe for reported radiation-induced changes in neuronal architecture 30, 34 .
Diffusion imaging
Novel imaging techniques can be used to study radiationinduced brain injury with enhanced sensitivity. Diffusionweighted imaging (DWI) is a more sensitive magnetic resonance based technique than standard structural MRI, and facilitates the detection of microstructural changes in white matter [141] [142] [143] [144] . Several studies have used DTI to assess the effects of radiation on seemingly normal brain white matter, particularly in an attempt to detect demyelination and axonal dysfunction seen in preclinical models 27, 131, 142, 145, 146 . Although one study suggested that DTI was only sensitive to radiation changes caused by a dose above a threshold of 45-50 Gy (REF. 147 ), others have shown changes in DTI metrics as a result of doses as low as 5-15 Gy, as well as dose-dependent changes seen on DTI 27, 146, 148 . Importantly, CNS white matter changes visible on DTI have appeared as early as 1 month after irradiation in patients with glioma 27 .
Synergism and anatomy
Connor and colleagues used advanced diffusion imaging with different diffusion weightings to show dosedependent and time-dependent white matter changes, which support a primarily extra-axonal component of white matter injury 27 . This finding suggests that early changes in the white matter microenvironment, such as neuroinflammation, can contribute to axonal injury. Another recent study, published in 2016, found that diffusion changes in individual white matter bundles were associated with the maximum dose delivered to those tracts, which the authors took to mean that CNS radiation injury occurred with each exposure, and the extent of damage was associated with the cumulative dose 149 . Besides dose-dependent effects, some brain areas seem to be particularly susceptible to white matter damage. A study of medulloblastoma survivors found greater diffusion changes in the frontal than in the parietal lobes 150 , and another study reported that after WBRT, the most prominent diffusion changes were seen in the fornix and cingula 151 . Several DTI studies have correlated white matter diffusion metrics with neurocognitive changes; for example, diffusion changes in the parahippocampal cingulum were associated with late decline in verbal recall after radiotherapy 152 . In another investigation, changes in diffusion parameters after WBRT in childhood cancer survivors correlated with intelligence quotient scores 153 .
Prospects for therapy
The lack of an overall mechanistic understanding of radiation-induced cognitive decline has forced clinical investigators to base the selection of candidate therapeutics on extrapolations from other CNS disorders, with the unsurprising result that patient responses have been mixed and short-lasting. Methylphenidate, which in the past has yielded some beneficial results, and memantine, which is in clinical testing, are both well tolerated and could be beneficial in patients receiving radiotherapy [154] [155] [156] [157] . An ongoing clinical trial Nature Reviews | Neurology (NRG CC-001) is examining memantine and WBRT with and without hippocampal sparing 158 . Acetylcholinesterase inhibitors, for example donepezil, are being pursued as therapeutics for Alzheimer disease and other dementias, as they have generated clinical benefit in patients 18, 159, 160 . On the other hand, anti-VEGF agents in patients with brain tumours have elicited serious concerns because, in clinical testing, the small molecule VEGF-A inhibitor bevacizumab seems to have worsened cognitive decline by possibly further inhibiting hippocampal plasticity 161 . New strategies for treating early radiation-induced CNS damage leading to cognitive deterioration could evolve from recent demonstrations that neuronal architecture can be damaged by radiation. Protein kinase C (PKC) overexpression reduces neuronal dendritic spine density in the hippocampus and PFC 163, 164 ; hence, PKC inhibitors, such as chelerythrine, and staurosporine analogues, such as midostaurin, which has been approved for use in patients, could help protect against deleterious changes in dendritic architecture 163, 164 . Benzothiazole amphiphiles promote the formation of dendritic spines in primary hippocampal neurons and could help to overcome the effects of radiation 165 . In addition, recent data suggest that stem and progenitor cells are likely to be key targets in radiation-induced brain injury and cognitive decline, and that stem cell niches are compromised by inflammation, vascular damage, and extracellular matrix destruction. Stem cell niches are distributed throughout the brain, so one approach to treating progressive neuronal and supporting cell loss could be to 're-engineer' CNS stem cell niches soon after irradiation 166 . Aggressive and early use of anti-inflammatory agents might also prove beneficial in limiting the inflammationrelated radiation damage. Moreover, direct injection or targeted administration could be used to deliver nanoparticles bearing biomimetic extracellular scaffolds, which have shown benefits in animal models of inflammatory CNS injury 167 . Other agents suitable for local delivery include biogels, bioactive signalling molecules for stem and progenitor cells, neuronal and supporting cell progenitors, and cellular precursors for the microvascular endothelium 166 . Moreover, systemic administration of small molecules, such as the selective serotonin reuptake inhibitor fluoxetine, have promoted the maturation of neurons and enhanced neurogenesis in animal models of radiation-induced CNS damage 168 .
Future studies could offer translational promise by focusing on newly emerging data showing early postirradiation changes that have the potential to affect neuronal support elements and the signalling environment in neuronal progenitor cell niches within the brain. In this regard, progress could be expected as a result of careful consideration of radiation dosing regimens, more-sensitive brain imaging methods for longitudinal biomarkers of white matter damage and cortical atrophy 18 , and anatomically oriented studies, especially in the context of CNS changes that develop before 6 months after irradiation. 18 In aggregate, these elements could facilitate a deeper appreciation of evolving radiation-induced brain abnormalities at multiple levels. This would certainly establish a more concrete foundation for rationally based studies aimed towards the identification of early preventive measures and therapies to impede degenerative processes before cognitive decline can become permanent.
Conclusions
Given the fact that the CNS contains many structures that are potentially sensitive to radiation, the irreversible cognitive deterioration that so often follows intracranial radiotherapy most probably has a multifactorial origin 27 . In this Review, we have posited the concept that early brain tissue abnormalities, which have in fact recently been identified, can lead to chronic interactive pathologies that progress to permanent cognitive deterioration. For example, early inflammation affects the hippocampal microenvironment and can exacerbate dysregulated neurogenesis because of neuronal damage and altered signalling in the progenitor cell microenvironment. Widespread inflammation can affect white matter integrity and function throughout the brain 169 . In addition, white matter comprises part of progenitor cell niches in the brain and white matter damage could, therefore, also adversely affect progenitors and repair mechanisms 170 .
A key need at the present juncture is to understand the different susceptibilities of brain compartments in patient populations and in distinct preclinical models. Moreover, it is essential to establish an experimentally validated definition of the nature and extent of early CNS damage depending on specific radiation dose ranges and fractionation schedules, as well as how such early damage evolves and synergizes over the long term to create permanent cognitive disability 26 .
